NYSE American - Delayed Quote • USD
NanoViricides, Inc. (NNVC)
At close: April 25 at 3:58 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
Low Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
High Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
Year Ago EPS | -0.14 | -0.15 | -- | -0.73 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.17 | -0.16 | -0.17 | -0.19 |
EPS Actual | -0.14 | -0.15 | -0.15 | -0.18 |
Difference | 0.03 | 0.01 | 0.02 | 0.01 |
Surprise % | 17.60% | 6.30% | 11.80% | 5.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
7 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
30 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
60 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
90 Days Ago | -0.17 | -0.17 | -0.68 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | NNVC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -35.70% | -- | -- | 2.60% |
Next Qtr. | -33.30% | -- | -- | 13.40% |
Current Year | -- | -- | -- | 5.20% |
Next Year | -52.10% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | EF Hutton: Buy to Buy | 2/16/2024 |
Reiterates | EF Hutton: Buy | 4/18/2023 |
Related Tickers
OKYO OKYO Pharma Limited
1.4467
+2.60%
EDSA Edesa Biotech, Inc.
4.4684
+2.25%
NBTX Nanobiotix S.A.
5.91
+0.17%
CTNM Contineum Therapeutics, Inc.
15.99
+0.38%
INAB IN8bio, Inc.
1.0400
-1.89%
IMNN Imunon, Inc.
1.4400
+10.77%
TVGN Tevogen Bio Holdings Inc.
0.8500
-43.33%
IPIX Innovation Pharmaceuticals Inc.
0.0020
-20.00%
ELYM Eliem Therapeutics, Inc.
3.3900
-7.38%
CANF Can-Fite BioPharma Ltd.
1.9200
-1.03%